Aktienanalyse zu Utah Medical Products Inc (UTMD)UTMDUtah Medical Products Inc

Utah Medical Products, Inc. manufactures and markets a range of specialty medical devices. The Company’s range of products includes those used in critical care areas and the labor and delivery departments of hospitals, as well as outpatient clinics and physicians offices. Its products are sold directly to end-user facilities in the United States, Ireland, United Kingdom, Canada, France and Australia, and through third party distributors in other outside the United States (OUS) markets. It offers fetal monitoring accessories. Its specialized labour and delivery tools include BT-Cath, CVX-Ripe, AROM-COT, MUC-X, and Cordguard. The Company’s vacuum-assisted delivery (VAD) systems include CMI soft silicone bell-shaped birthing cups and reusable hand-held vacuum pumps, which are the safest products available for use in vacuum-assisted operative deliveries. Its neonatal intensive care products include Disposa-Hood and GESCO. It also distributes harm-reduction medical devices. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).

Utah Medical Products is currently a hold. The stock is trading at $70.55, which is 72.7% of its 52-week range, indicating it is closer to its high than its low. The forward P/E ratio is 13.04, suggesting it is reasonably valued compared to its earnings potential. However, the RSI is at 44.47, indicating it is not yet oversold, and the recent 5-day change of -4.04% shows a downward trend that may continue in the short term.